Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
04/04/2012 | CN102397395A 人参七味酒 Qiwei ginseng wine |
04/04/2012 | CN102397361A 一种感冒止咳颗粒的制备方法 A method for the preparation of cold and cough particles |
04/04/2012 | CN102397352A 一种中医治疗失眠的口服药物 One kind of Chinese medicine treatment of oral drugs for insomnia |
04/04/2012 | CN102397351A Traditional Chinese medicinal composition for treating insomnia |
04/04/2012 | CN102397319A 一种治疗百日咳的药物 A medication pertussis |
04/04/2012 | CN102397317A Method for producing soybean Genistin and application of soybean Genistin in preparation of estrogenic drugs or female health food |
04/04/2012 | CN102397315A 一种中医治疗面神经麻痹药物 One kind of Chinese medicine treatment of facial nerve paralysis drugs |
04/04/2012 | CN102397310A 三七三醇组和银杏叶提取物组合物及制剂及用途 Panaxtriol group and Ginkgo biloba extract composition and preparation and use |
04/04/2012 | CN102397308A 蛇床子催眠活性组分的制备工艺 Preparation of the active ingredient hypnotic Osthol |
04/04/2012 | CN102397301A 使用酶的银耳提取物制备方法及含有它的记忆增进用组合物 Using an enzyme preparation containing the fungus extract and memory enhancing its composition |
04/04/2012 | CN102397285A Application of hyperin in preparation of medicines for resisting vascular dementia |
04/04/2012 | CN102397279A Application of friedelin-3 beta-alcohol to preparation of vascular dementia-resisting medicaments |
04/04/2012 | CN102397272A Application of butylphthalide and derivatives thereof in preparation of medicines for preventing and treating ALS |
04/04/2012 | CN102397261A 盐酸奈福泮药物组合物及其制备方法 Nefopam pharmaceutical composition and its preparation method |
04/04/2012 | CN102397234A Nerves-calming and sleep-helping foot bath liquid |
04/04/2012 | CN102397229A Refreshing and brain invigorating liquid shampoo |
04/04/2012 | CN102396950A 一种保健养生枕 A health regimen pillow |
04/04/2012 | CN102396949A Rose pillow core filling for treating insomnia |
04/04/2012 | CN102396935A 一种保健柳丝草席 A health Stir mats |
04/04/2012 | CN101897541B 一种中草药保健香 One kind of herbal health incense |
04/04/2012 | CN101885697B 一种制备奥拉西坦的方法 A method for preparing oxiracetam |
04/04/2012 | CN101856482B 一种治疗精神病症的纯中药制剂及其制备方法 A method of treating mental disorders pure Chinese medicine and its preparation method |
04/04/2012 | CN101829314B 茶皂素足浴粉 Foot powder tea saponin |
04/04/2012 | CN101610774B 治疗脱髓鞘疾病的方法 Method of treating demyelinating diseases |
04/04/2012 | CN101321736B 对M<sub>1</sub>受体具有活性的化合物及其在医药中的用途 For M <sub> 1 </ sub> receptor active compounds and their use in medicine |
04/03/2012 | US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
04/03/2012 | US8148418 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
04/03/2012 | US8148417 Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
04/03/2012 | US8148394 Azaindoles having serotonin receptor affinity |
04/03/2012 | US8148390 Monocyclic anilide spirolactam CGRP receptor antagonists |
04/03/2012 | US8148385 Substituted [1,2,3] triazolo[4,5-d]pyrimidine derivatives as ADP P2Y12 receptor antagonists |
04/03/2012 | US8148379 Use of lurasidone (N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl-methyl]-1-cyclohexylmethyl]-2,3-bicycl[2.2.1]heptanedicarboxyimide) |
04/03/2012 | US8148364 Substituted bicyclic pyrimidone derivatives |
04/03/2012 | US8148355 Phophylactic and therapeutic use of hydroxysteroids |
04/03/2012 | US8148148 Neural progenitor cell populations |
04/03/2012 | US8148109 Interferon-like proteins and uses thereof |
04/03/2012 | US8147809 Soft anticholinergic esters |
04/03/2012 | CA2677872C A composition for selective serotonin reuptake inhibition and process thereof |
04/03/2012 | CA2648157C 1-alkyl-5-aryl-3-arylamino-1h-1,2,4-triazoles as positive allosteric modulators of the alpha 7 receptor |
04/03/2012 | CA2617725C Novel cysteine protease inhibitors and their therapeutic applications |
04/03/2012 | CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands |
04/03/2012 | CA2494569C An analgesic agent for newborn or fetal subjects |
04/03/2012 | CA2493812C Novel imidazole compounds, method for preparing same and use thereof as medicines |
03/29/2012 | WO2012040651A2 Controlled release formulations of opioids |
03/29/2012 | WO2012040641A2 Compounds for treating neurodegenerative diseases |
03/29/2012 | WO2012040595A2 Administration of serine protease inhibitors to the stomach |
03/29/2012 | WO2012040465A2 Multipotent stem cells and uses thereof |
03/29/2012 | WO2012040404A1 Monohydrate of an azaadamantane derivative |
03/29/2012 | WO2012040258A2 Therapeutic piperazines |
03/29/2012 | WO2012040230A1 Imidazotriazinone compounds |
03/29/2012 | WO2012039979A2 Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
03/29/2012 | WO2012039578A2 Composition for preventing and treating amyloid diseases, comprising cyclophilin b |
03/29/2012 | WO2012039513A1 Proliferation, separation and transplantation of suppressive neural progenitor cells, and substance capable of enhancing proliferation of the cells |
03/29/2012 | WO2012039472A1 Drug against central nervous system inflammation |
03/29/2012 | WO2012039469A1 Method for screening binding inhibitor of rage and age |
03/29/2012 | WO2012039460A1 Substituted amide compound |
03/29/2012 | WO2012039371A1 Cyclopropane compound |
03/29/2012 | WO2012038956A1 Method of treating neurodegenerative diseases |
03/29/2012 | WO2012038850A1 Pyridmidones for treatment of potassium channel related diseases |
03/29/2012 | WO2012038813A1 Buprenorphine analogs |
03/29/2012 | WO2012038743A1 Pyrazolopyridines as inhibitors of the kinase lrrk2 |
03/29/2012 | WO2012038492A1 Novel substituted amino-, imino-1,2,4 triazine derivatives |
03/29/2012 | WO2012038438A1 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
03/29/2012 | WO2012038417A1 Substituted amino - benzoic acid derivatives as inhibitors of dna methyltransferases |
03/29/2012 | WO2012037834A1 5α-ANDROSTANE (ALKYL)-3β,5,6β-TRIOL INJECTION AND PREPARATION METHOD THEREFOR |
03/29/2012 | WO2012037782A1 Tricyclic compounds, preparation methods, and their uses |
03/29/2012 | WO2012037634A1 Compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors |
03/29/2012 | WO2012001411A3 Pharmaceutical compositions for sublingual delivery of opioids |
03/29/2012 | WO2011150175A3 Compositions and methods for pain reduction |
03/29/2012 | WO2011150160A9 Method of preventing and treating inflammatory diseases and disorders with abscisic acid |
03/29/2012 | WO2011141822A3 Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors |
03/29/2012 | WO2011119777A3 Compositions and methods for treatment of neurodegenerative disease |
03/29/2012 | WO2011116282A3 Nicotinic acetylcholine receptor agonists |
03/29/2012 | WO2011010084A8 Cyclosporin conjugates |
03/29/2012 | US20120077878 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract |
03/29/2012 | US20120077876 Method For Improved Bioactivation Of Pharmaceuticals |
03/29/2012 | US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
03/29/2012 | US20120077856 Pharmaceutical product |
03/29/2012 | US20120077855 Crystalline tripeptide epoxy ketone protease inhibitors |
03/29/2012 | US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
03/29/2012 | US20120077839 Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto |
03/29/2012 | US20120077838 Beta-2-Adrenoreceptor Agonists |
03/29/2012 | US20120077836 Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof |
03/29/2012 | US20120077832 Besylate salt of a btk inhibitor |
03/29/2012 | US20120077830 Caspase inhibitors and uses thereof |
03/29/2012 | US20120077828 Chemical compounds |
03/29/2012 | US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists |
03/29/2012 | US20120077825 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
03/29/2012 | US20120077821 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
03/29/2012 | US20120077818 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof |
03/29/2012 | US20120077816 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors |
03/29/2012 | US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors |
03/29/2012 | US20120077814 Sulfonamide, sulfamate, and sulfamothioate derivatives |
03/29/2012 | US20120077813 Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease |
03/29/2012 | US20120077808 Niacin Mimetics, and Methods of Use Thereof |
03/29/2012 | US20120077807 Niacin mimetics, and methods of use thereof |
03/29/2012 | US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same |
03/29/2012 | US20120077802 Histamine h3 inverse agonists and antagonists and methods of use thereof |
03/29/2012 | US20120077800 Methods for Treating Antipsychotic-Induced Weight Gain |
03/29/2012 | US20120077799 Heterocyclic compound and use thereof |